The total number of outstanding common shares for Tonix Pharmaceuticals Holding Corp. fluctuates dynamically over time due to corporate actions, periodic capital-raising initiatives, secondary public equity offerings, warrant exercises, and structural adjustments like reverse stock splits executed to maintain exchange listing compliance. Because small-cap biotechnology firms frequently utilize equity financing to fund research pipelines and extend cash runways, exact share counts are updated continuously in official quarterly financial filings submitted to the U.S. Securities and Exchange Commission.